Abdolkarim Sheikhi is a renowned Iranian immunologist born in Dezful, Iran, on December 22, 1965. With a distinguished academic career, he is currently a Full Professor at Dezful University of Medical Sciences. He has held positions at various universities, including Zanjan University and Queen’s University. Sheikhi’s research mainly focuses on immunology, particularly cancer immunology and immune cell interactions. He has a deep commitment to teaching and has mentored numerous students. His professional contributions include several prestigious publications, with his work widely cited in international journals. 📚💡🧬
Profile
Google scholar
Education & Experience
Abdolkarim Sheikhi earned his B.Sc. in Biological Sciences from Shahid Chamran University (1989), an M.Sc. in Medical Immunology from Tarbiat Modarress University (1992), and a Ph.D. in Medical Immunology from Shiraz University of Medical Sciences (2002). His career includes various academic positions such as Lecturer and Professor at Zanjan, Dezful, and Queen’s Universities. He has gained experience as a visiting scientist in multiple countries, including Canada, Germany, and the Netherlands. Sheikhi is also known for establishing immunology and cell culture labs at universities and clinics. 🧑🎓🌍🔬
Professional Development
Abdolkarim Sheikhi’s career is marked by continuous professional development. He has attended specialized courses at Queen’s University, including Radiation Safety, RT-PCR, and Animal Care. His postdoctoral work in various labs worldwide, including in Canada, Germany, and the Netherlands, has advanced his skills in molecular immunology, cancer research, and NK cell studies. Sheikhi has also contributed to the development of immunology labs and clinics focused on infertility treatment and autoimmune therapy. His role in various scientific committees and editorial boards has further honed his expertise and global impact in the field of immunology. 💼🧬💪
Research Focus
Abdolkarim Sheikhi’s research primarily focuses on immunology, with particular interest in natural killer (NK) cells, cancer immunotherapy, and immune cell interactions. His studies explore the role of soluble HLA molecules in immune responses and their interaction with NK cells in cancerous environments. Sheikhi has made significant contributions to understanding immune modulation, such as the effects of probiotics on cytokine secretion and the development of bispecific antibodies for tumor targeting. His work also investigates the immunological mechanisms in autoimmune diseases and metabolic disorders, offering valuable insights into therapeutic interventions. 🧬💉🔬
Publications
- “Kefir: a powerful probiotics with anticancer properties” (216 citations, 2017) 🧑🔬📖
- “Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide” (174 citations, 2008) 🌱💡
- “Study of Porphyromonas gingivalis in periodontal diseases: A systematic review and meta-analysis” (113 citations, 2017) 🦠📑
- “Circulating levels of interleukin-35 in patients with multiple sclerosis” (113 citations, 2015) 🧠🦠
- “Higher circulating levels of chemokine CXCL10 in patients with breast cancer” (92 citations, 2016) 💪🩺
- “A review of trafficking and activation of uterine natural killer cells” (77 citations, 2005) 🌸🧬